Abbott neurostimulation system Proclaim XR gets USFDA nod for chronic pain Medical Dialogues Bureau29 Sept 2019 4:25 AMProclaim XR is currently under review for CE Mark. It is the latest advancement from Abbott, featuring upgradeable software and consumer-friendly...
Twin Approvals: Abbott bags CE Mark for its Mechanical Heart Valve and Occluder devices Medical Dialogues Bureau19 Sept 2019 6:47 AMABBOTT PARK -- Abbott today announced approvals in Europe for two of its life-saving pediatric devices. The Masters HP™ 15mm rotatable mechanical...
Diabetes Management: Sanofi, Abbott team up to integrate glucose sensing, insulin delivery technologies Farhat Nasim16 Sept 2019 4:00 AMSanofi and Abbott will take an approach to connected care by developing tools that combine the revolutionary FreeStyle Libre technology with insulin...
NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details Farhat Nasim16 Aug 2019 10:31 AMNew Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
Novartis Expiry of Patent for Blockbuster Vildagliptin to Clear Way for Competitors Farhat Nasim30 July 2019 8:38 AMNew Delhi: The patent protection of blockbuster anti-diabetic drug Vildagliptin manufactured by the Swiss drugmaker, Novartis, will soon expire on...
Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit Medical Dialogues Bureau19 July 2019 9:32 AMAbbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump...
NPPA fixes retail price of 14 combo drugs including Aspirin, Paracetamol, Vitamin D3; Details Farhat Nasim27 Jun 2019 10:37 AMNew Delhi: Through a recent notification, the government regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail...
CDSCO Committee rejects proposal for additional Indications of Dapaglofizin Meghna A Singhania5 May 2019 7:22 AMNew Delhi: British-Swedish multinational drugmaker, AstraZeneca's stride to win approval from the Indian drug regulators for the additional...
Abbott launches first smartphone compatible insertable cardiac monitor to detect arrhythmias in India Ruby Khatun Khatun21 Dec 2017 5:09 AMNew Delhi: Abbott recently launched the latest in Insertable Cardiac Monitor (ICM) across India, providing patients access to the world's first and...
SC refers 344 fixed dose combination medicines to Drug Advisory Board for Re-examination Ruby Khatun Khatun16 Dec 2017 10:10 AMNew Delhi: The Supreme Court referred 344 fixed dose combination (FDC) medicines, including well- known brands like Corex cough syrup, Vicks Action...
4 Pharma Giants face price fixing allegations on Vidagliptin: CCI starts probe Ruby Khatun Khatun15 Dec 2017 11:45 AMMumbai: Trouble is mounting for 4 big pharma companies over price fixing of an anti-diabetic drug. An investigation has initiated on drug makers...
Abbott India Q2 profit rises 83 percent to Rs 137.52 crore Ruby Khatun Khatun14 Nov 2017 4:53 AMNew Delhi: Drug firm Abbott India reported 83.31% jump in net profit to Rs137.52 crore for the September quarter on account of robust sales.It had...
